Birsin, Z.; Odabaşı Bükün, H.; Nazlı, İ.; Alkan, O.; Günaltılı, M.; Çerme, E.; Aliyev, V.; Cebeci, S.; Jeral, S.; Abbasov, H.;
et al. Is Body Mass Index a Prognostic Factor in Metastatic HER2-Positive Breast Cancer? A Real-World Multicenter Study. Medicina 2025, 61, 1604.
https://doi.org/10.3390/medicina61091604
AMA Style
Birsin Z, Odabaşı Bükün H, Nazlı İ, Alkan O, Günaltılı M, Çerme E, Aliyev V, Cebeci S, Jeral S, Abbasov H,
et al. Is Body Mass Index a Prognostic Factor in Metastatic HER2-Positive Breast Cancer? A Real-World Multicenter Study. Medicina. 2025; 61(9):1604.
https://doi.org/10.3390/medicina61091604
Chicago/Turabian Style
Birsin, Zeliha, Hülya Odabaşı Bükün, İsmail Nazlı, Onur Alkan, Murat Günaltılı, Emir Çerme, Vali Aliyev, Selin Cebeci, Seda Jeral, Hamza Abbasov,
and et al. 2025. "Is Body Mass Index a Prognostic Factor in Metastatic HER2-Positive Breast Cancer? A Real-World Multicenter Study" Medicina 61, no. 9: 1604.
https://doi.org/10.3390/medicina61091604
APA Style
Birsin, Z., Odabaşı Bükün, H., Nazlı, İ., Alkan, O., Günaltılı, M., Çerme, E., Aliyev, V., Cebeci, S., Jeral, S., Abbasov, H., Evrensel, T., Papila, Ç., Demirci, N. S., & Alan, Ö.
(2025). Is Body Mass Index a Prognostic Factor in Metastatic HER2-Positive Breast Cancer? A Real-World Multicenter Study. Medicina, 61(9), 1604.
https://doi.org/10.3390/medicina61091604
